| Reference(英) |
|
8997
Takeshi Hanagiri, Yoshiki Shigematsu, Koji Kuroda, Tetsuro Baba, Hironobu Shiota, Yoshinobu Ichiki, Yoshika Nagata, Manabu Yasuda, Tomoko So, Mitsuhiro Takenoyama, Fumihiro Tanaka
Antitumor Activity of Human γδ T Cells Transducted With CD8 and With T-cell Receptors of Tumor-Specific Cytotoxic T Lymphocytes
Cancer Sci
2012
103 (8), 1414-9
PubMed ID: 22621620
DOI: 10.1111/j.1349-7006.2012.02337.x
|
|
8999
Hidetaka Uramoto, Hidehiko Shimokawa, Yoshika Nagata, Kenji Ono, Takeshi Hanagiri
EGFR-activating Mutations Are Not Present in Breast Tumors of Japanese Patients
Anticancer Res
2010
30 (10), 4219-22
PubMed ID: 21036744
|
|
8990
Kosei Yasumoto, Takeshi Hanagiri, Mitsuhiro Takenoyama
Lung Cancer-Associated Tumor Antigens and the Present Status of Immunotherapy Against Non-Small-Cell Lung Cancer
Gen Thorac Cardiovasc Surg
2009
57 (9), 449-57
PubMed ID: 19756930
DOI: 10.1007/s11748-008-0433-6
|
|
3628
Baba T, Hanagiri T, Ichiki Y, Kuroda K, Shigematsu Y, Mizukami M, Sugaya M, Takenoyama M, Sugio K, Yasumoto K.
Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
Cancer Sci
2007
98(11):1795-802
PubMed ID: 17725806
DOI: 10.1111/j.1349-7006.2007.00586.x
|
|
8995
Takashi Fukuyama, Yoshinobu Ichiki, Sousuke Yamada, Yoshiki Shigematsu, Tetsuro Baba, Yoshika Nagata, Makiko Mizukami, Masakazu Sugaya, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto
Cytokine Production of Lung Cancer Cell Lines: Correlation Between Their Production and the Inflammatory/Immunological Responses Both in Vivo and in Vitro
Cancer Sci
2007
98 (7), 1048-54
PubMed ID: 17511773
DOI: 10.1111/j.1349-7006.2007.00507.x
|
|
9004
Makiko Mizukami, Takeshi Hanagiri, Manabu Yasuda, Koji Kuroda, Yoshiki Shigematsu, Tetsuro Baba, Takashi Fukuyama, Yoshika Nagata, Tetsuya So, Yoshinobu Ichiki, Masakazu Sugaya, Tomoko So, Mitsuhiro Takenoyama, Kenji Sugio, Kosei Yasumoto
Antitumor Effect of Antibody Against a SEREX-defined Antigen (UOEH-LC-1) on Lung Cancer Xenotransplanted Into Severe Combined Immunodeficiency Mice
Cancer Res
2007
67 (17), 8351-7
PubMed ID: 17804751
DOI: 10.1158/0008-5472.CAN-06-3889
|
|
8988
Takashi Fukuyama, Takeshi Hanagiri, Mitsuhiro Takenoyama, Yoshinobu Ichiki, Makiko Mizukami, Tetsuya So, Masakazu Sugaya, Tomoko So, Kenji Sugio, Kosei Yasumoto
Identification of a New Cancer/Germline Gene, KK-LC-1, Encoding an Antigen Recognized by Autologous CTL Induced on Human Lung Adenocarcinoma
Cancer Res
2006
66 (9), 4922-8
PubMed ID: 16651449
DOI: 10.1158/0008-5472.CAN-05-3840
|
|
7413
Mizukami M, Hanagiri T, Baba T, Fukuyama T, Nagata Y, So T, Ichiki Y, Sugaya M, Yasuda M, Takenoyama M, Sugio K, Yasumoto K.
Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course.
Cancer Sci
2005
96(12):882-8
PubMed ID: 16367908
DOI: 10.1111/j.1349-7006.2005.00119.x
|
|
8948
Yoshika Nagata, Takeshi Hanagiri, Mitsuhiro Takenoyama, Takashi Fukuyama, Makiko Mizukami, Tetsuya So, Yoshinobu Ichiki, Masakazu Sugaya, Kenji Sugio, Kosei Yasumoto
Identification of the HLA-Cw*0702-restricted Tumor-Associated Antigen Recognized by a CTL Clone From a Lung Cancer Patient
Clin Cancer Res
2005
11 (14), 5265-72
PubMed ID: 16033845
DOI: 10.1158/1078-0432.CCR-04-2542
|
|
8998
Yoshinobu Ichiki, Takeshi Hanagiri, Mitsuhiro Takenoyama, Tetsuro Baba, Takashi Fukuyama, Yoshika Nagata, Makiko Mizukami, Tetsuya So, Masakazu Sugaya, Manabu Yasuda, Tomoko So, Kenji Sugio, Kosei Yasumoto
Tumor Specific Expression of survivin-2B in Lung Cancer as a Novel Target of Immunotherapy
Lung Cancer
2005
48 (2), 281-9
PubMed ID: 15829330
DOI: 10.1016/j.lungcan.2004.10.017
|
|
3638
Sugaya M, Takenoyama M, Osaki T, Yasuda M, Nagashima A, Sugio K, Yasumoto K.
Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy.
Chest
2002
122(1):282-8
PubMed ID: 12114371
DOI: 10.1378/chest.122.1.282
|
|
3636
Takenoyama M, Yoshino I, Eifuku R, So T, Imahayashi S, Sugaya M, Yasuda M, Inoue M, Ichiyoshi Y, Osaki T, Nagashima A, Nomoto K, Yasumoto K.
Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.
Jpn J Cancer Res
2001
92(3):309-15
PubMed ID: 11267941
DOI: 10.1111/j.1349-7006.2001.tb01096.x
|
| 利用者成果(英) |
|
11040
Koh Furugaki, Marie Mochizuki, Mirei Kohno, Sei Shu, Naoki Harada, Yasushi Yoshimura
Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion
BMC Cancer
2019
19(1):301
PubMed ID: 30943926
DOI: 10.1186/s12885-019-5527-2
|
|
8945
Chinami Masuda, Mieko Yanagisawa, Keigo Yorozu, Mitsue Kurasawa, Koh Furugaki, Nobuyuki Ishikura, Toshiki Iwai, Masamichi Sugimoto, Kaname Yamamoto
Bevacizumab Counteracts VEGF-dependent Resistance to Erlotinib in an EGFR-mutated NSCLC Xenograft Model
Int J Oncol
2017
51 (2), 425-434
PubMed ID: 28627678
DOI: 10.3892/ijo.2017.4036
|
|
8946
Masanobu Nishidate, Kaname Yamamoto, Chinami Masuda, Hiroaki Aikawa, Mitsuhiro Hayashi, Takehiko Kawanishi, Akinobu Hamada
MALDI Mass Spectrometry Imaging of Erlotinib Administered in Combination With Bevacizumab in Xenograft Mice Bearing B901L, EGFR-mutated NSCLC Cells
Sci Rep
2017
7 (1), 16763
PubMed ID: 29196706
DOI: 10.1038/s41598-017-17211-6
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト
